⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20762170 | 0.72 | GSK3A (0.40) | — | |
| SCHEMBL12395179 | 0.65 | — | — | |
| SCHEMBL21599326 | 0.63 | — | — | |
| SCHEMBL1100011 | 0.62 | — | — | |
| SCHEMBL22294701 | 0.58 | — | — | |
| SCHEMBL21788823 | 0.57 | GSK3A (0.32) | — | |
| SCHEMBL15468843 | 0.57 | TOP2A (0.30) | — | |
| SCHEMBL18512524 | 0.56 | GSK3A (0.31) | — | |
| SCHEMBL12411017 | 0.56 | GSK3A (0.41) | — | |
| SCHEMBL784042 | 0.56 | GSK3A (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3668881-B1 | PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS | AGIOS PHARMACEUTICALS INC (US) | 2023-10-04 | — | — | EP | disclosed |
| EP-4026838-A1 | PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS | Agios Pharmaceuticals, Inc. (US) | 2022-07-13 | — | — | EP | disclosed |
| EP-3668513-B1 | PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS | AGIOS PHARMACEUTICALS INC (US) | 2021-11-10 | — | — | EP | disclosed |
| WO-2019035863-A1 | PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS | AGIOS PHARMACEUTICALS, INC. (US) | 2019-02-21 | — | — | WO | disclosed |